|
|
Editorial |
| The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention? |
2017 |
| MV Blagosklonny
|
|
Full Article (PDF)
|
|
Spotlight on Apoptosis |
| Review |
| Kinases: positive and negative regulators of apoptosis |
2019 |
| RA Franklin & JA McCubrey
|
|
Abstract
Full Article (PDF)
|
|
Review and Meeting Report |
| Dissecting the pathways to death |
2035 |
| PT Daniel
|
|
Abstract
Full Article (PDF)
|
|
Original Manuscripts |
| Apoptosis |
| Expression and activity of caspases 1 and 3 in myelodysplastic syndromes |
2045 |
| D Boudard,
O Sordet,
C Vasselon,
V Revol,
M-F Berthéas,
D Freyssenet,
A Viallet,
S Piselli,
D Guyotat & L Campos
|
|
Abstract
Full Article (PDF)
|
|
| Therapy |
| Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies |
2052 |
| A Mengarelli,
AP Iori,
C Guglielmi,
MP Perrone,
M Gozzer,
C Girmenia,
G Cimino,
AM Testi,
R Ricci,
L De Felice,
G Girelli,
F Mandelli & W Arcese
|
|
Abstract
Full Article (PDF)
|
|
| Prognosis in AML |
| Prognosis of patients with a second relapse of acute myeloid leukemia |
2059 |
| B Stoiser,
P Knöbl,
C Fonatsch,
OA Haas,
G Mitterbauer,
A Weltermann,
K Geissler,
P Valent,
W Sperr,
I Pabinger,
K Lechner & U Jaeger
|
|
Abstract
Full Article (PDF)
|
|
| Autologous Bone Marrow Transplantation in CML |
Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon- |
2064 |
| M Michallet,
A Thiébaut,
I Philip,
C Charrin,
C Vigouroux,
X Thomas,
K Bilger,
A Belhabri,
D Guyotat,
B Corront,
B Salles,
C Dumontet,
PY Péaud,
JP Vilque,
A Devidas & D Fière
|
|
Abstract
Full Article (PDF)
|
|
| Clinical Laboratory Correlates in AML |
| Protean clinical manifestations in children with leukemias containing MLL-AF10 fusion |
2070 |
| L Gore,
J Ess,
MA Bitter,
L McGavran,
L Meltesen,
Q Wei & SP Hunger
|
|
Abstract
Full Article (PDF)
|
|
| Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies |
2076 |
| SW Van Gool,
E Van Kerschaver,
P Brock,
H Pottel,
F Hulstaert,
E Vanmechelen,
A Uyttebroeck,
A Van De Voorde & H Vanderstichele
|
|
Abstract
Full Article (PDF)
|
|
| Sensitivity and Resistance to Therapy |
| Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes |
2085 |
| E Solary,
L Mannone,
D Moreau,
D Caillot,
R-O Casasnovas,
H Guy,
M Grandjean,
J-E Wolf,
F André,
P Fenaux,
P Canal,
B Chauffert,
A Wotawa,
M Bayssas & P Genne
|
|
Abstract
Full Article (PDF)
|
|
| Studies on B Cell Precursors |
| Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells |
2095 |
| FE Bertrand,
CE Eckfeldt,
AS Lysholm & TW LeBien
|
|
Abstract
Full Article (PDF)
|
|
| Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classification |
2103 |
| B Lemmers,
C Arnoulet,
C Fossat,
H Chambost,
D Sainty,
J Gabert & C Schiff
|
|
Abstract
Full Article (PDF)
|
|
| Signal Transduction |
| A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamide |
2112 |
| A Arcangeli,
L Fontana,
O Crociani,
A Cherubini,
G Hofmann,
E Piccini,
S Polvani,
M D’Amico,
M Carlà & M Olivotto
|
|
Abstract
Full Article (PDF)
|
|
| Modifications in phospholipase D activity and isoform expression occur upon maturation and differentiation in vivo and in vitro in human myeloid cells |
2118 |
| M El Marjou,
V Montalescot,
A Buzyn & B Geny
|
|
Abstract
Full Article (PDF)
|
|
| Tumor Suppressor Genes in AML |
| Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31 |
2128 |
| H Xie,
Z Hu,
B Chyna,
SK Horrigan & CA Westbrook
|
|
Abstract
Full Article (PDF)
|
|
| Cell Cycle and Progenitors |
| Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML) |
2135 |
| Y Guan & DE Hogge
|
|
Abstract
Full Article (PDF)
|
|
| Lymphoma |
| Genetic instability is associated with histological transformation of follicle center lymphoma |
2142 |
| M Nagy,
M Balázs,
Z Ádám,
Z Petkó,
B Tímár,
Z Szereday,
T László,
RA Warnke & A Matolcsy
|
|
Abstract
Full Article (PDF)
|
|
| Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin’s lymphoma B cell line |
2149 |
| M Irisarri,
J Plumas,
T Bonnefoix,
M-C Jacob,
C Roucard,
M-A Pasquier,
J-J Sotto & A Lajmanovich
|
|
Abstract
Full Article (PDF)
|
|
| A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin’s lymphoma and two or three adverse prognostic factors |
2159 |
| C Dumontet,
C Thieblemont,
D Espinouse,
F Bouafia,
O Hequet,
G Salles & B Coiffier
|
|
Abstract
Full Article (PDF)
|
|
Bio-Technical Methods Section (BTS) |
| mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method |
2166 |
| MG Rots,
JC Willey,
G Jansen,
CH Van Zantwijk,
P Noordhuis,
JP DeMuth,
E Kuiper,
AJP Veerman,
R Pieters & GJ Peters
|
|
Abstract
Full Article (PDF)
|
|
| Detection of hTERT protein by flow cytometry |
2176 |
| ASM Ali,
R Chopra,
J Robertson & NG Testa
|
|
Abstract
Full Article (PDF)
|
|
| Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro |
2182 |
| K Tarte,
G Fiol,
J-F Rossi & B Klein
|
|
Abstract
Full Article (PDF)
|
|
Spotlight on Long-Term Results of Pediatric ALL Clinical Trials from 12 Study Groups World Wide |
| Long-term results of large prospective trials in childhood acute lymphoblastic leukemia |
2193 |
| M Schrappe,
B Camitta & C-H Pui
|
|
Full Article (PDF)
|
|
| Note from the Editor |
2195 |
| N Muller-Bérat, MD
|
|
Full Article (PDF)
|
|
Original Manuscripts |
| Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982-1995 |
2196 |
| V Conter,
M Aricò,
MG Valsecchi,
G Basso,
A Biondi,
E Madon,
F Mandelli,
G Paolucci,
A Pession,
C Rizzari,
R Rondelli,
L Zanesco & G Masera for the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP)
|
|
Abstract
Full Article (PDF)
|
|
| Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995 |
2205 |
| M Schrappe,
A Reiter,
M Zimmermann,
J Harbott,
W-D Ludwig,
G Henze,
H Gadner,
E Odenwald & H Riehm
|
|
Abstract
Full Article (PDF)
|
|
| Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995 |
2223 |
| PS Gaynon,
ME Trigg,
NA Heerema,
MG Sensel,
HN Sather,
GD Hammond & WA Bleyer
|
|
Abstract
Full Article (PDF)
|
|
| Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92 |
2234 |
| DO Harms & GE Janka-Schaub on behalf of the COALL Study Group
|
|
Abstract
Full Article (PDF)
|
|
| Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991 |
2240 |
| WA Kamps,
AJP Veerman,
ER van Wering,
JF van Weerden,
R Slater & A van der Does-van den Berg
|
|
Abstract
Full Article (PDF)
|
|
| Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995) |
2247 |
| LB Silverman,
L Declerck,
RD Gelber,
V Kimball Dalton,
BL Asselin,
RD Barr,
LA Clavell,
CA Hurwitz,
A Moghrabi,
Y Samson,
MA Schorin,
JM Lipton,
HJ Cohen & SE Sallan
|
|
Abstract
Full Article (PDF)
|
|
| Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report |
2257 |
| E Vilmer,
S Suciu,
A Ferster,
Y Bertrand,
H Cavé,
A Thyss,
Y Benoit,
N Dastugue,
M Fournier,
G Souillet,
A-M Manel,
A Robert,
B Nelken,
F Millot,
P Lutz,
X Rialland,
F Mechinaud,
P Boutard,
C Behar,
J-M Chantraine,
E Plouvier,
G Laureys,
P Brock,
A Uyttebroeck,
G Margueritte,
D Plantaz,
L Norton,
N Francotte,
J Gyselinck,
C Waterkeyn,
G Solbu,
N Philippe & J Otten
|
|
Abstract
Full Article (PDF)
|
|
| Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation |
2267 |
| G Gustafsson,
K Schmiegelow,
E Forestier,
N Clausen,
A Glomstein,
G Jonmundsson,
L Mellander,
A Mäkipernaa,
R Nygaard & UM Saarinen-Pihkala on behalf of the Nordic Society of Pediatric Haematology and Oncology (NOPHO)
|
|
Abstract
Full Article (PDF)
|
|
| Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994 |
2276 |
| KW Maloney,
JJ Shuster,
S Murphy,
J Pullen & BA Camitta
|
|
Abstract
Full Article (PDF)
|
|
| Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children’s Research Hospital |
2286 |
| C-H Pui,
JM Boyett,
GK Rivera,
ML Hancock,
JT Sandlund,
RC Ribeiro,
JE Rubnitz,
FG Behm,
SC Raimondi,
A Gajjar,
B Razzouk,
D Campana,
LE Kun,
MV Relling & WE Evans
|
|
Abstract
Full Article (PDF)
|
|
| Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children’s Cancer Study Group 1981-1995 |
2295 |
| M Tsuchida,
K Ikuta,
R Hanada,
T Saito,
K Isoyama,
K Sugita,
Y Toyoda,
A Manabe,
K Koike,
A Kinoshita,
M Maeda,
K Ishimoto,
T Sato,
Y Okimoto,
T Kaneko,
M Kajiwara,
M Sotomatsu,
Y Hayashi,
H Yabe,
R Hosoya,
Y Hoshi,
M Ohira,
F Bessho,
Y Tsunematsu,
I Tsukimoto & S Nakazawa for the Tokyo Children's Cancer Study Group
|
|
Abstract
Full Article (PDF)
|
|
| Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997 |
2307 |
| OB Eden,
G Harrison,
S Richards,
JS Lilleyman,
CC Bailey,
JM Chessells,
IM Hann,
FGH Hill & BES Gibson on behalf of the Medical Research Council Childhood Leukaemia Working Party
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| An unusual presentation of a case of T cell angiotropic (intravascular) lymphoma |
2321 |
| G Isimbaldi,
L Corral,
S Songia,
MG Valente,
S De Bianchi & A Biondi
|
|
Full Article (PDF)
|
|
| Intrathecal mitozantrone has to be prohibited |
2323 |
| JH Dalle,
A Lambilliotte,
AS Defachelles,
F Mazingue & B Nelken
|
|
Full Article (PDF)
|
|
| Is there any genetic susceptibility to acute promyelocytic leukemia? |
2324 |
| X Thomas
|
|
Full Article (PDF)
|
|
Author Index |
|
2327 |
|
|
|
Full Article (PDF)
|
|
Keyword Index |
|
2337 |
|
|
|
Full Article (PDF)
|
|
